United Guardian (UG) Cash & Equivalents (2010 - 2026)
United Guardian's (UG) quarterly Cash & Equivalents came in at $2.4 million in Q2 2026, up 35.19% year-over-year from $1.8 million in Q2 2025, and up 224.89% quarter-over-quarter from $735854.0 in Q1 2026.
Analysis
United Guardian (UG) Cash & Equivalents (2010 - 2026) Analysis & Trends
United Guardian has disclosed Cash & Equivalents across 17 years of filings, most recently posting $2.4 million for Q2 2026.
- In Q2 2026, Cash & Equivalents rose 35.19% year-over-year to $2.4 million; the TTM figure through Jun 2026 stood at $2.4 million (up 35.19% YoY), while the FY2025 annual figure was $1.3 million, down 33.3% from the prior year.
- Cash & Equivalents came in at $2.4 million for Q2 2026 at United Guardian, up from $735854.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $8.4 million in Q2 2024 to a low of $355572.0 in Q2 2022.
- Average Cash & Equivalents over 5 years is $3.0 million, with a median of $1.5 million recorded in 2025.
- Year-over-year, Cash & Equivalents surged 1723.23% in 2023 and sank 82.06% in 2025.
- Over 5 years, Cash & Equivalents stood at $830452.0 in 2022, then soared by 892.61% to $8.2 million in 2023, then slumped by 77.25% to $1.9 million in 2024, then tumbled by 33.3% to $1.3 million in 2025, then surged by 91.09% to $2.4 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $2.4 million in Q2 2026, $735854.0 in Q1 2026, and $1.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.68 Bn | 624.92 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 441.40 Bn | 434.83 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 365.79 Bn | 358.65 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 266.44 Bn | 258.75 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Pfizer | 158.97 Bn | 147.27 Bn | 10.94 Bn | 976.00 Mn |
| 6 | Sanofi | 52.38 Bn | 45.00 Bn | 10.79 Bn | 7.38 Bn |
| 7 | Revolution Medicines | 44.09 Bn | 44.09 Bn | - | 815.44 Mn |
| 8 | Incyte | 25.52 Bn | 20.99 Bn | 1.57 Bn | 3.98 Bn |
| 9 | United Therapeutics | 21.52 Bn | 18.86 Bn | 683.80 Mn | 1.80 Bn |
| 10 | United Guardian | 32.46 Mn | 22.87 Mn | 1.55 Mn | 2.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.39 Mn |
| Mar 31, 2026 | 735,854.00 |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 860,836.00 |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 8.41 Mn |
| Mar 31, 2024 | 7.07 Mn |
| Dec 31, 2023 | 8.24 Mn |
| Sep 30, 2023 | 7.12 Mn |
| Jun 30, 2023 | 6.48 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 830,452.00 |
| Sep 30, 2022 | 496,526.00 |
| Jun 30, 2022 | 355,572.00 |
| Mar 31, 2022 | 511,500.00 |
| Dec 31, 2021 | 531,213.00 |
| Sep 30, 2021 | 691,921.00 |